Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy L Simonsen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Using alpha wisely: improving power to detect multiple QTLKaty L Simonsen, Lauren M McIntyre
Molecular Biology and Evolution|November 26, 2004
Genomic haplotype blocks may not accurately reflect spatial variation in historic recombination intensityKoen J F Verhoeven, Katy L Simonsen
Genetics|April 19, 2005
Model selection in binary trait locus mappingCynthia J Coffman, R W Doerge, Katy L Simonsen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2018
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapiesKaty L Simonsen, Paula M Fracasso, Steven H Bernstein, et al.
Journal of the American College of Cardiology|January 29, 2008
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 studyOlga A Iakoubova, Marc S Sabatine, Charles M Rowland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2008
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapyMarc S Sabatine, Lynn Ploughman, Katy L Simonsen, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
The New England Journal of Medicine|January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaHussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Using alpha wisely: improving power to detect multiple QTLKaty L Simonsen, Lauren M McIntyre
Molecular Biology and Evolution|November 26, 2004
Genomic haplotype blocks may not accurately reflect spatial variation in historic recombination intensityKoen J F Verhoeven, Katy L Simonsen
Genetics|April 19, 2005
Model selection in binary trait locus mappingCynthia J Coffman, R W Doerge, Katy L Simonsen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2018
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapiesKaty L Simonsen, Paula M Fracasso, Steven H Bernstein, et al.
Journal of the American College of Cardiology|January 29, 2008
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 studyOlga A Iakoubova, Marc S Sabatine, Charles M Rowland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2008
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapyMarc S Sabatine, Lynn Ploughman, Katy L Simonsen, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
The New England Journal of Medicine|January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaHussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Pageof 1